drug
as of 2026-07-01Talnetant
talnetant
at a glance
small molecule
Pre-approval / investigational in the US
Developed by GlaxoSmithKline
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients
NCT00300963Phase 2Completed
Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia
NCT00103727Phase 2Completed
Schizophrenia Study In Adults
NCT00049946Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication